2020;31:11891205.e13
Your exact dose count depends on your specific escalation rate and target maintenance dose, which PlexusDx clinicians personalize based on your health profile and genetic insights
GLP-1 RAs Hold Promising Potential for Reduction of Cardiometabolic Risk Factors additional benefits : Brain: Appetite suppression, nerve protection, and decreased neuroinflammation Heart: Decreased blood pressure (systolic and diastolic), reduced total cholesterol levels, lowered endothelial dysfunction, and increased heart rate Liver: Decreased glucose production Pancreas: Increased insulin secretion, decreased glucagon secretion, B islet cell proliferation GI Tract: Decreased gastric emptying Because these drugs cause weight loss, it is not clear whether the GLP-1 RAs or the weight loss reduces cardiometabolic risks
If nausea is a problem, tapering the dose increase or taking ginger tea frequently ameliorates it
Mechanisms and possible hepatoprotective effects of glucagon-like peptide-1 receptor agonists and other incretin receptor agonists in non-alcoholic fatty liver disease
The Takeaway Low libido is a common problem in women, especially as they age and go through the menopausal transition